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Two iron(III) complexes of Ciprofloxacin were synthesized by reaction of the ligand with iron(III) 
chloride hexahydrate in different solutions. The nature of bonding of the ligands and the structure of 
the isolated metal complexes were elucidated on the basis of their physical and spectroscopic studies. 
The infrared spectra suggest that two classes of compounds were obtained: molecular complex in 
which the ligands were bidentately bonded to the metal through the ring carbonyl oxygen and one of 
the oxygen of the carboxylate group and the ionic complex consisting of a tetrachlorometalate ion 
which is electrostatically attached to the ligand. The antibacterial activities of the products against 
various microorganisms were tested and it was established that their activities were comparable with 
those of their parent drug. Toxicological studies were carried out in which therapeutic doses of the 
Ciprofloxacin drug and the metal complexes were administered to albino rats and the results showed 
that the metal complexes are not toxic. 
 





According to Chu et al. (1996) there is a worldwide 
agreement over the present need to develop novel 
agents to treat bacterial infections that have become 
increasingly unresponsive to standard antibacterial thera-
py. Emergence of bacteria resistance to a number of 
antimicrobial agents is becoming a major health problem. 
This has led to studies on the metal complexes of 1-
cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-
3-quinoline carboxylic acid hydrochloride 
(C17H18FN3O3.HCl.H2O) (Ciprofloxacin), a fluoroquinolone 
derivative, in which biological studies were carried out to 
determine their potency (Wise et al., 1983; Kucers and 
Mck.Bennet, 1987; Singleton, 1997). Some copper(II) 
Ciprofloxacin complexes (cfH2)(cfH3)[CuC4]Cl.H2O, 
[Cu(cf)(H2O)3]SO4.2H2O  and [Cu(cf)2]Cl2.6H2O were 
tested against the growth of various gram positive and 
gram negative microorganism (Turel, 2002; Drevenski et 
al., 2002). The complexes showed comparable antimi-
crobial activity with the free ligand. 




*Corresponding author. E-mail: jobaleye@yahoo.com. 
Ciprofloxacin (Figure 1) and two synthesized and analyz-
ed iron (III) complexes of Ciprofloxacin were carried out. 
 
 
MATERIALS AND METHOD 
 
Ciprofloxacin was obtained from Sigma-Aldrich Chemie, Germany. 
The metal salt used is FeCl3.6H2O. Reagents and solvents were 
used without further purification. 
Melting point was determined using Gallenkamp melting point 
apparatus. The conductivity was measured by using the Hanna 
instrument conductivity meter. The analysis of chemical elements 
(C, H, and N) was carried out at the laboratory of Desert Analytics, 
Tucson, Arizona, USA. The metal concentration was determined on 
an alpha 4 atomic absorption spectrophotometer at the central 
laboratory, O.A.U, Ile-Ife, Nigeria. The samples were digested in 
concentrated HCl and diluted with a known volume of water. The 
I.R. spectra were recorded using KBr pellets with Buck scientific 







Twenty millilitres of the aqueous Ciprofloxacin (1.0 mmole) in a 250 



















solution of the FeCl3.6H2O (0.5 mmole) were added to the ligand 
solution. The mixture was stirred with a magnetic stirrer for 2 h and 
left to stand overnight. The orange precipitate formed was filtered 
and washed with distilled water. 
 
 
Compound 2 -(H3Cip)[FeCl4]Cl.H2O 
 
1 mmole of the Ciprofloxacin was dissolved in 10 ml of 1M HCl 
solution. To this was added 20 ml of FeCl3.6H2O (1 mmole) 
dissolved in 1M HCl. The solution was stirred with a magnetic stirrer 
for 1 h. The colour changed from orange to red. The resulting 
solution was then concentrated and products collected by filtration.  
 
 
Determination of the Minimum Inhibitory Concentration (MIC) 
and Minimum Bactericidal concentration (MBC) 
 
To each of a series of sterile stoppered test tubes, a standard 
volume of medium that will support the growth of the test organism 
was added; this was followed by the addition of 0.10, 0.15, 0.20, 
0.25, 0.30, 0.35, 0.40, 0.50, 0.80, 1.00, 1.50, 2.00, 3.00, 4.00, 5.00, 
6.00 and 7.00 ml of each of the antimicrobial metal complex and 
ligand solutions representing 10, 15, 20, 25, 30, 35, 40, 45, 50, 80, 
100, 150, 200, 300, 400, 500, 600 and 700 µg/ml respectively in 
final mixture of 10 ml. Standard volume of the inoculum (0.2 ml) of 
each of the test organism was added to the reacting mixture. Two 
controls were set up for each of the test, one in which the test 
sample (antimicrobial) was omitted and the other in which the test 
organism was omitted. All the tubes were incubated at 35oC for 24 
h.  
All tubes showing turbidity (evidence of growth) were removed 
while those showing no turbidity were subcultured into nutrient 
broth by transferring a loopful of the culture which has been 
properly shaken into 10 mls of the broth and incubated for 8 h at 
35oC. This broth culture was further subcultured on to nutrient agar 
media by a single stroke streaking and incubated at 35oC for 24 h. 
The plates were observed for growth after the period of incubation. 
The minimum concentration plates showing no growth after this 





The drugs were dissolved in distilled water and administered orally 
to the male albino rats in proportion to their body weight. The 
control groups were given only distilled water. The test solutions 
were prepared based on therapeutic dose as follows: Ciprofloxacin 
- 500 mg, per 70 kg body weight, twice daily for seven days after 
which they were sacrificed. The homogenates of the liver, kidney, 
small intestine and heart were prepared in ice-cold 0.25  M  sucrose  




solution to give a final volume of five times the original tissue weight 
(1:5, w:v).The tissue homogenates were all diluted in ratio 1:20 with 
saline water before enzyme assay. All enzymes activity was 




RESULTS AND DISCUSSION 
 
Compound 1- [Fe(Cip)2Cl2]Cl.6H2O 
 
Bright orange, amorphous product; 70.2%; m.p > 400oC; 
Soluble in H2O, MeOH, EtOH; Mol. cond. () = 0.62 
Scm2mol-1; IR(KBr)Vmax/cm-1: 3500 - 3000(OH for water 
molecule) 1621 (C=O)p, 1573, (OCO)as, 1475 (C-C +C-
N), 1383 (OCO)s; Anal. Calcd. for C34H46N6F2O12FeCl3 
(Mr= 931.15): C= 43.76, H= 5.18, N= 9.01 and Fe= 
5.98%. Found: Fe 5.73%. 
 
 
Compound 2 - (H3Cip)[FeCl4]Cl.H2O 
 
Deep red crystalline product; 52.2%; m.p 250 - 252 oC; 
Soluble in H2O and MeOH. Insoluble in EtOH; Mol. cond. 
() = 1.09 Scm2mol-1; IR(KBr)Vmax/cm-1: 3562 - 
3000(OH for water molecule), 1743 (C=O)c 1641 (C=O)p, 
1514 (C-C +C-N),  1407.7(OCO)s, 1251.9 (C-F). 
Anal.Calcd. for C17H22N3FO4FeCl5 (Mr= 583.75): C= 
34.92, H= 3.79, N= 7.19 and Fe= 9.55% Found: C 35.41, 
H 4.02, N 7.24, Fe 9.18%; 
From the elemental analysis data, the mole ratio, anion 
present and water molecules were determined. The 
AgNO3 solution was used to confirm the presence of 
chloride ions outside the coordination sphere (The CHN 
for Compound I was not determined.) Chloride ions from 
the metal salts appears in [Fe(Cip)2Cl2]Cl.6H2O complex 
either within and outside the coordination spheres as 
shown in the conductivity measurements. The terminal 
nitrogen on the 7-piperazinyl group is protonated where 
simple chloride ions are present to balance the charge on 
the complex as has been shown in similar studies (Turel, 
2002; Turel et al., 2003; Al- Mustafa, 2002; Zupani et 
al., 2001). Also the presence of water (lattice or 
coordinated water) is shown by the broad peak at 3600 – 





It has been observed from the previous studies that 
fluoroquinolones coordinate to metals through the ring 
carbonyl oxygen and one of the oxygens of the 
carboxylate group as observed for [Fe(Cip)2Cl2]Cl.6H2O. 
This is supported by the absence of the v(C=O)c 
frequencies and the presence of v(OCO)as and v(OCO)as 
in the infrared spectra of [Fe(Cip)2Cl2]Cl.6H2O.  
In the IR spectra of (H3Cip)[FeCl4]Cl.H2O, the intense 
band at 1743 cm-1 was assigned to (C=O)c. The position 
of (C=O)p appears at higher frequency around 1630 cm
-1.  




Table 1. Minimum inhibitory concentration (ug/ml) and minimum bactericidal concentration (ug/ml) of Ciprofloxacin, 
[Fe(Cip)2Cl2]Cl.6H2O-1 and (H3Cip)[FeCl4]Cl.H2O-2. 
 
Minimum inhibitory concentration (ug/ml Minimum bactericidal concentration (ug/ml)  
Bacteria Ciprofloxacin Compound 1 Compound 2 Ciprofloxacin Compound 1 Compound 2 
S. typhi 60 180 80 80 100 100 
Shigella spp 150 150 150 180 180 180 
E. coli 450 250 450 500 300 500 
Klebsiella spp. 150 500 450 200 550 500 
S. aureus 150 400 450 200 450 500 
Pseudomonas spp. 150 250 180 180 300 200 






















































This indicates that the carboxylic group is not 
deprotonated, therefore the Ciprofloxacin ligand is not 
directly coordinated to the metal. It is proposed that in 
this class of compounds, the ligand exist as a singly (+1) 
or doubly (+2) protonated cation as for 
(H3Cip)[FeCl4]Cl.H2O The positive charge on the 
ciprofloxacium ion is neutralized by the tetrachlorome-
talate anion and any extra chloride ion. Similar ionic 
complexes consisting of a tetrachlorometalate ion which 
is electrostatically attached to the ligand have being 
reported (Zupani et al., 2001; Turel et al., 1996). 
 Based on these results, the following structures were 
proposed for the compounds [Fe(Cip)2Cl2]Cl.6H2O and 





The result of the minimum inhibitory concentrations 
(bacteriostatic) (MIC) and the minimum bactericidal 
concentrations (MBC) of the ligands and metal comple-
xes determined are presented in Table 1. Generally, 
ligands and metal complexes showed antimicrobial effect 
against the tested organism species except against the 
molds of Penicillim and Aspergillus as presented. 
Neissera gonorrhoea was the most sensitive organism to 
the fluoroquinolones and their complexes. Some of the 
metal complexes showed comparable activity or greater 
activity against some of the microorganisms in compa-
rison to the parent compounds. The MIC of the samples 
against the various isolates ranged from 20 to 450 g/ml of 
the antimicrobial dilutions, while that of the MBC ranged 
from 30 to 550 g/ml.  
 
 
Results of toxicological study  
 
Figures 4 – 8 show the effects of Ciprofloxacin and its 
metal complexes on some enzymes and tissue/ 





The observed reduction in liver-body weight ratio caused 
by Ciprofloxacin and its metal complexes suggests that 
the drugs may retard the growth of the liver. This may 
result from the inhibition of some metabolic processes 
(e.g. the synthesis of DNA), which are needed for normal  






















































Figure 4. Effects of Ciprofloxacin and its metal complexes on ALP activity in some tissues. 
[Where Cip = Ciprofloxacin, 1 = [Fe(Cip)2Cl2]Cl.H2O and 2 = (H3Cip)[FeCl4]Cl.H2O-]. Values with 



























































Figure 5. Effects of Ciprofloxacin and its metal complexes on ACP activity in some tissues. [Where Cip = 
Ciprofloxacin, 1 = [Fe(Cip)2Cl2]Cl.H2O and 2 = (H3Cip)[FeCl4]Cl.H2O-]. Values with different superscripts are 
significantly different at P < 0.05. 
  





























































Figure 6. Effects of Ciprofloxacin and its metal complexes on ALT activity in some tissues. [Where Cip = Ciprofloxacin, 





















































Figure 7. Effects of Ciprofloxacin and its metal complexes on AST activity in some tissues. [Where Cip= 
Ciprofloxacin, 1 = [Fe(Cip)2Cl2]Cl.H2O and 2 = (H3Cip)[FeCl4]Cl.H2O-]. Values with different superscripts are 
significantly different at P < 0.05. 
 















































Figure 8. Effects of Ciprofloxacin and its metal complex on tissue-bodyweight ratio in some tissues. 
[Where Cip = Ciprofloxacin, 1 = [Fe(Cip)2Cl2]Cl.H2O and 2 = (H3Cip)[FeCl4]Cl.H2O-]. Values with different 




cell growth and proliferation (Dollery, 1999). However, the 
reduction caused by compound 2 is not as severe as 
that caused by Ciprofloxacin. The same pattern is exhi-
bited with respect to heart- body weight ratio, although 
compound 2 did not cause any significant reduction in 
heart-body weight ratio compared to control. This result 
suggests that compound 2 may have a less adverse 
effect on the liver and heart compared to Ciprofloxacin 
and compound 1. Also prolonged administration of 





The fact that there was no significant difference in serum 
ALP activities of Ciprofloxacin and its metal complexes 
compared with control suggests that the integrity of the 
plasma membrane of the cells in the various tissues 
might not have been adversely affected. This is because 
ALP is a membrane-bound enzyme often used to assess 
the integrity of the plasma membrane and endoplasmic 
reticulum and an increase in ALP activity of the serum 
implies membrane damage to the tissues (Akanji et al., 
1993). Since there was no increase in serum ALP 
activities of the various groups, the observed decrease in 
ALP activities in the small intestine (of rats administered 
with Ciprofloxacin), and heart (of rats administered with 1 
and 2) may imply inactivation of the enzyme in situ by the 
drugs or their metabolites. Moreover, the observed 
increase in the ALP activities in the liver (of rats 
administered Ciprofloxacin) and small intestine (of rats 
administered 1 and 2) suggests an enhancement of the 
activities of the existing enzymes by the drugs and their 
metabolites. The increase may also be as a result of 
stress imposed on the tissue by the drugs, which may 
lead to loss of the enzyme molecule through leakage into 
extracellular fluid, which has not been significantly 
noticed in the serum. In a bid to offset this stress, the 
tissue may increase the de novo synthesis of the 
enzyme, thus accounting for the increase in ALP 
activities in these tissues (Umezawa and Hooper, 1982; 





The serum ACP activities also showed a similar trend 
with serum ALP activities in rats administered Cipro-
floxacin and metal complexes suggesting that the 
integrity of the lysosomal membrane in the cells of the 
various tissues has not been compromised. This is 
because ACP is a lysosomal enzyme, which is often used 
to monitor prostatic cancer (Burtis and Ashwood, 1999). 
Since there was no increase in serum ACP activities, the 
observed increase in ACP activities in the kidney (of rats 
administered 1), small intestine  (of  rats  administered  2)  




and heart (of rats administered 1) suggests either an 
increased production of ACP due to stimulation of the 
enzyme synthesis or facilitated activities of existing 
enzymes. However, the observed reduction in ACP 
activities in the liver (of rats administered 2) could be due 
to inactivation of the enzyme synthesis or activity by the 





In a similar trend with the ALP and ACP activities, the 
serum ALT activities in rats administered with Cipro-
floxacin and 1 did not show significant increase 
compared with control, which suggests that the integrity 
of the cell membranes in the various tissues studied has 
not been adversely affected. However 2 caused a 
significant increase in serum ALT activity compared with 
control, with a corresponding increase in liver ALT 
activity, but comparable with the parent drug. For the 
treatment groups that did not show an increase in serum 
ALT activity, observed increases therefore in ALT 
activities in the liver and small intestine (of rats 
administered Ciprofloxacin) suggests stimulation of the 
enzyme activities by the drugs and their metabolites 
which could be due to stress imposed on the tissues by 





Ciprofloxacin and the metal complex groups did not have 
a significant increase in serum AST activities compared 
with control as in ALT activities. This suggests that the 
integrity of the cell membranes of the various tissues 
(especially the heart and liver) were not adversely 
affected. However, observed increases in AST activities 
in the liver (of rats administered 1 and 2), kidney (of rats 
administered 1 and 2) and small intestine (of rats 
administered 1) without corresponding increase in serum 
AST activities for the groups may imply enhancement of 





The stoichiometries and the structure of the complexes 
reported here are based essentially on the microanaly-
tical data obtained. Based on this, structures are 
proposed such that steric constraints are eliminated. The 
Ciprofloxacin ligand formed molecular complex in the 
zwitterionic form (Cip±) for [Fe(Cip)2Cl2]Cl.6H2O while it 
formed ionic complex in the acidic cation (Cip+) for 
(H3Cip)[FeCl4]Cl.H2O as reported in some previous work 
(Turel, 2002; Al- Mustafa, 2002). 
In general, the metal complexes were most active 
against N. gonorrhoea, most especially 





Ciprofloxacin and metal complexes, the metal complexes 
[Fe(Cip)2Cl2]Cl.6H2O-1 and (H3Cip)[FeCl4]Cl.H2O-2 had 
less negative effect on the body tissues studied 
compared to their parent drug. Therefore the metal 
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